세계의 흡수성 혈관 스캐폴드 시장 보고서(2025년)
Resorbable Vascular Scaffolds Global Market Report 2025
상품코드 : 1720880
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,532,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,442,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,352,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

흡수성 혈관 스캐폴드 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간 동안의 성장은 노인 인구에서 관상동맥질환(CAD) 및 말초동맥질환(PAD)의 위험 증가, 수술 절차 연구개발(R&D) 자금 증가, 고령화 인구 증가, 의료비 지출 증가 등에 기인할 수 있습니다.

심혈관 질환의 유병률 증가는 흡수성 혈관 스캐폴드 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질병은 잘못된 생활 습관 선택, 노화, 고혈압, 고콜레스테롤, 당뇨병, 흡연, 유전적 소인 등의 요인에 의해 영향을 받습니다. 흡수성 혈관 스캐폴드는 서서히 용해하면서 혈류를 회복시키는 일시적인 구조 지원을 제공하여 영구적인 임플란트에 따른 장기적인 합병증을 최소화하고 자연적인 혈관 치유와 기능성을 촉진하는 것으로, 심혈관 치료에 변혁을 가져옵니다. 또한 심장병은 같은 주의 전체 사망자의 약 17%를 차지했으며, 2022년에는 8,972명이 사망했습니다.

흡수성 혈관 스캐폴드 시장의 주요 기업은 생체적합성을 높이고 우수한 기계적 지지를 제공하는 마그네슘 골격을 개발하고 있습니다. 마그네슘 스캐폴드는 천연 혈관 치유를 촉진하는 동시에 기존 폴리머 기반 스캐폴드와 관련된 염증과 합병증을 줄여줍니다. 독일에 본사를 둔 의료 기기 회사인 바이오트로닉은 무릎 아래의 프리솔브 레조버블 마그네슘 스캐폴드(BTK RMS)로 FDA 혁신 기기 지정을 받았습니다. 만성 사지 위협 허혈(CLTI) 환자를 위해 설계된 프리솔브 RMS는 무릎 이하(BTK) 중재를 위한 고급 치료 옵션을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Resorbable vascular scaffolds are medical devices designed to treat vascular diseases by temporarily supporting blood vessels and gradually dissolving once their function is complete. These scaffolds help restore normal blood flow and promote natural vessel healing, offering a safer and more effective alternative to permanent stents by reducing long-term complications.

The main product designs of resorbable vascular scaffolds include multilumen and single-lumen types. Multilumen resorbable vascular scaffolds are advanced bioresorbable devices with multiple channels that enhance support, improve blood flow, and facilitate vessel healing in complex vascular conditions. These scaffolds are made from materials such as poly-glycolic acid, poly-l-lactic acid, and poly-l-lactic-co-glycolic acid and are deployed using balloon-expandable or self-expandable techniques. They are primarily used in treating coronary artery disease, peripheral vascular disease, and pulmonary artery disease, serving end users such as ambulatory surgical centers, hospitals, and specialty clinics.

The resorbable vascular scaffolds market research report is one of a series of new reports from The Business Research Company that provides resorbable vascular scaffolds market statistics, including resorbable vascular scaffolds industry global market size, regional shares, competitors with a resorbable vascular scaffolds market share, detailed resorbable vascular scaffolds market segments, market trends and opportunities, and any further data you may need to thrive in the resorbable vascular scaffolds industry. This resorbable vascular scaffolds market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The resorbable vascular scaffolds market size has grown rapidly in recent years. It will grow from $0.46 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth during the historic period can be attributed to the increasing prevalence of cardiovascular diseases, rising consumer health awareness, a growing incidence of coronary artery disease (CAD), the increasing adoption of minimally invasive procedures, and the rising prevalence of diabetes.

The resorbable vascular scaffolds market size is expected to see rapid growth in the next few years. It will grow to $0.83 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth during the forecast period can be attributed to the increasing risk of coronary artery disease (CAD) and peripheral artery disease (PAD) in the geriatric population, rising funding for research and development (R&D) in surgical procedures, a growing aging population, increasing healthcare expenditure, and the rising prevalence of coronary artery disease. Key trends expected during this period include a shift toward drug-eluting devices for angioplasty, technological advancements and product innovations, and continuous improvements in stent and diagnostic technologies.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the resorbable vascular scaffolds market. These diseases are influenced by factors such as poor lifestyle choices, aging, high blood pressure, high cholesterol, diabetes, smoking, and genetic predispositions. Resorbable vascular scaffolds are transforming cardiovascular treatment by providing temporary structural support to restore blood flow while gradually dissolving, minimizing long-term complications associated with permanent implants, and promoting natural vessel healing and functionality. For example, in September 2024, the Minnesota Department of Health, a US-based state agency, reported that in 2023, 4% of adults in Minnesota approximately 180,000 people had experienced a heart attack. Additionally, heart disease accounted for around 17% of all deaths in the state, resulting in 8,972 fatalities in 2022. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the resorbable vascular scaffolds market.

Leading companies in the resorbable vascular scaffolds market are developing magnesium scaffolds to enhance biocompatibility and provide superior mechanical support. Magnesium scaffolds facilitate natural vessel healing while reducing inflammation and complications associated with conventional polymer-based scaffolds. In March 2024, Biotronik, a Germany-based medical device company, received FDA breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). Designed for patients with chronic limb-threatening ischemia (CLTI), Freesolve RMS offers an advanced treatment option for below-the-knee (BTK) interventions. It incorporates BIOmag magnesium alloy and Orsiro drug-eluting stent (DES) coating technology, improving safety, deliverability, and vessel support while providing short-term structural reinforcement during the healing process.

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition allows Abbott to expand its vascular portfolio, enhance treatment options, and improve care for patients with peripheral and coronary artery disease. Cardiovascular Systems Inc. (CSI) is a US-based medical device company specializing in developing innovative atherectomy systems used for treating peripheral and coronary artery diseases.

Major players in the resorbable vascular scaffolds market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Getinge Group, Biotronik, LivaNova plc, Lepu Medical Technology, Gore Medical, Biosensors International, Blue Medical, Reva Medical, Elixir Medical, S3V Vascular Technologies, Amaranth Medical Inc., Meril Life Sciences Pvt. Ltd., Arterius Limited, Zorion Medical, Kyoto Medical Planning Co. Ltd., and ICON Interventional Systems.

North America was the largest region in the resorbable vascular scaffolds market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in resorbable vascular scaffolds report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the resorbable vascular scaffolds market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The resorbable vascular scaffolds market consists of sales of resorbable scaffold systems, resorbable scaffold delivery devices, and bioresorbable stents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Resorbable Vascular Scaffolds Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on resorbable vascular scaffolds market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for resorbable vascular scaffolds ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The resorbable vascular scaffolds market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Resorbable Vascular Scaffolds Market Characteristics

3. Resorbable Vascular Scaffolds Market Trends And Strategies

4. Resorbable Vascular Scaffolds Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Resorbable Vascular Scaffolds Growth Analysis And Strategic Analysis Framework

6. Resorbable Vascular Scaffolds Market Segmentation

7. Resorbable Vascular Scaffolds Market Regional And Country Analysis

8. Asia-Pacific Resorbable Vascular Scaffolds Market

9. China Resorbable Vascular Scaffolds Market

10. India Resorbable Vascular Scaffolds Market

11. Japan Resorbable Vascular Scaffolds Market

12. Australia Resorbable Vascular Scaffolds Market

13. Indonesia Resorbable Vascular Scaffolds Market

14. South Korea Resorbable Vascular Scaffolds Market

15. Western Europe Resorbable Vascular Scaffolds Market

16. UK Resorbable Vascular Scaffolds Market

17. Germany Resorbable Vascular Scaffolds Market

18. France Resorbable Vascular Scaffolds Market

19. Italy Resorbable Vascular Scaffolds Market

20. Spain Resorbable Vascular Scaffolds Market

21. Eastern Europe Resorbable Vascular Scaffolds Market

22. Russia Resorbable Vascular Scaffolds Market

23. North America Resorbable Vascular Scaffolds Market

24. USA Resorbable Vascular Scaffolds Market

25. Canada Resorbable Vascular Scaffolds Market

26. South America Resorbable Vascular Scaffolds Market

27. Brazil Resorbable Vascular Scaffolds Market

28. Middle East Resorbable Vascular Scaffolds Market

29. Africa Resorbable Vascular Scaffolds Market

30. Resorbable Vascular Scaffolds Market Competitive Landscape And Company Profiles

31. Resorbable Vascular Scaffolds Market Other Major And Innovative Companies

32. Global Resorbable Vascular Scaffolds Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Resorbable Vascular Scaffolds Market

34. Recent Developments In The Resorbable Vascular Scaffolds Market

35. Resorbable Vascular Scaffolds Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기